DIREVO Industrial Biotechnology: Manfred Eigen Laboratory Inaugurated
DIREVO Industrial biotechnology GmbH announced that it has completed the move to new premises of its own at the BioCampus Cologne. This is another important step in building up the company to figure as a major player in industrial biotechnology. It was further announced that DIREVO is dedicating its core laboratory to its co-founder and shareholder, Nobel Prize laureate Prof. Dr. Manfred Eigen. His scientific discoveries and inventions laid the foundations for DIREVO’s technology platform. DIREVO Industrial Biotechnology GmbH was founded in July 2008 as a spin-out from DIREVO Biotech AG and sold in September 2008, just prior to the acquisition of the parent company by Bayer HealthCare AG. Since then DIREVO has built its own, proprietary ultra-high-throughput screening facility. The new and further improved platform is able to handle up to 150,000 individual screenings per day. This unrivaled number makes it an extremely powerful tool for the screening of customized enzymes and strains with improved characteristics.
Other news from the department business & finance
